Announcements Trials
Browse Landscape

Phase

Phase NA 8Phase EARLY_PHASE1 5Phase 4 3Phase 2 3Phase 1 2Phase 2/3 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1

Conditions

Polycystic Ovary Syndrome 1Hyperandrogenism 1Brain Neoplasms 1

Interventions

Cyclophosphamide 415Radiotherapy 274fludarabine 237Gemcitabine 210Cisplatin 202Nivolumab 184pembrolizumab 181Paclitaxel 176Carboplatin 167Magnetic Resonance Spectroscopy 163fludarabine phosphate 156Irinotecan 134Bevacizumab 133Cytarabine 128Capecitabine 124Temozolomide 123Specimen Handling 122Radiosurgery 117Docetaxel 116Biopsy 115Ipilimumab 114Dexamethasone 113Radiation 109Oxaliplatin 109Fluorouracil 109Etoposide 108Rituximab 107Filgrastim 99Lenalidomide 98Everolimus 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Progesterone × Clear all
NCT01428089 2023-11-02

Suppression of Daytime and Nighttime Luteinizing Hormone Frequency by Progesterone

University of Virginia

Phase 1 Unknown
40 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism

NCT04414020 2020-06-04

Cytoprotective Effect and Clinical Outcome of Perioperative Proesterone in Brain Tumors

Minia University

Phase 1 Unknown
26 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡